Initial public offering of BONESUPPORT HOLDING AB (SE) on Nasdaq Stockholm — SEK 575 million

Carnegie acted as joint global co-ordinator and joint bookrunner in the initial public offering of BONESUPPORT on Nasdaq Stockholm. BONESUPPORT is an innovative and rapidly growing commercial stage orthobiologics company, based in Lund, Sweden. The Company develops and commercializes innovative injectable bioceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs directly into the bone void. June 2017.